• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar

Carter Ledyard & Milburn LLP

  • Professionals
  • Practices
  • News & Insights
  • Thought Leadership
  • Featured Series
  • Looking Ahead
  • Events
  • Our Firm
Stay Connected
Stay Connected
Subscribe To Our Publications
PrintPDFEmail

Carter Ledyard Advises Client PainReform Ltd., an Israeli Biotechnology Company, in its Initial Public Offering on NASDAQ

September 3, 2020/less than a minute

Carter Ledyard client, PainReform Ltd., a clinical stage Israeli biotechnology company focused on the reformulation of established therapeutics, was advised by Carter Ledyard’s Steven J. Glusband and Guy Ben-Ami, together with Israeli firm Doron Tikotzky Kantor Gutman & Amit Gross, in its $20,000,000 initial public offering on September 1, 2020. PainReform’s proprietary extended release drug-delivery system is designed to provide an extended period of post-surgical pain relief without the need for repeated dose administration while reducing the potential need for the use of opiates.

sidebar

Related Practices

  • Israeli Cross-Border
  • Corporate

Related Professionals

  • Media item displaying Steven J. Glusband

    Steven J. Glusband

    /

    Partner

    D/212-238-8605
    glusband@clm.com
  • Guy Ben-Ami Feature

    Guy Ben-Ami

    /

    Partner

    D/212-238-8658
    benami@clm.com
Copyright © 2023 Carter Ledyard & Milburn LLPPowered by Content Pilot
  • Sitemap
  • Disclaimer
  • Cookie Policy
  • Privacy Policy
  • Subscribe
  • Contact

Meritas

Meritas.org Logo

Legal Link

Legal link dot org logo